Act Advisors, Llc. Compass Therapeutics, Inc. Transaction History
Act Advisors, Llc.
- $181 Million
- Q4 2024
A detailed history of Act Advisors, Llc. transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Act Advisors, Llc. holds 10,528 shares of CMPX stock, worth $26,320. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,528Holding current value
$26,320% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CMPX
# of Institutions
81Shares Held
92.3MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$55.9 Million0.97% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$27.8 Million0.04% of portfolio
-
Blackstone Inc New York, NY10MShares$25.1 Million0.09% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$16.5 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA5.64MShares$14.1 Million1.62% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $253M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...